The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes

NCT02307695 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

184

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Saxagliptin
DRUG: Insulin

Sponsor

Nanjing Medical University